1 Standard Chemotherapy + Mitazalimab, More Than 90% Effective In The Treatment Of Pancreatic Cancer! May 15, 2025
2 Significantly Longer Survival In Refractory Breast Cancer With The Addition Of Eganelisib To Standard Treatment! May 10, 2025
3 Fda Accepts Zuranolone's Nda Application And Grants It Priority Review For The Treatment Of Mdd And Pdd Jan 26, 2025
Read More Medical Neoadjuvant Chemotherapy Reduces Colon Cancer Recurrence Rate By 28%, With Fewer Post-Operative Complications, Study Shows May 08, 2025
Read More Medical New Technology Can Break The Blood-Brain Barrier To Directly Treat Brain Tumours, Is Potent And Less Toxic, And Deserves Attention! May 09, 2025
Read More Apparatus Significantly Longer Survival In Refractory Breast Cancer With The Addition Of Eganelisib To Standard Treatment! May 10, 2025
